Endoscopic Management for Recurrent Pancreatitis: Expert Review Endoscopic Management for Recurrent Pancreatitis: Expert Review
Controversy remains regarding the benefit of endoscopic retrograde cholangiopancreatography in the management of unexplained recurrent acute pancreatitis.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 12, 2022 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Sedation for Patients Undergoing ERCP Sedation for Patients Undergoing ERCP
This study looked at two different propofol regimens for sedation in patients undergoing endoscopic retrograde cholangiopancreatography. Which has a better safety profile?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 9, 2022 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Single-use Duodenoscope Is Cost-effective in ERCP Single-use Duodenoscope Is Cost-effective in ERCP
The EXALT Model-D beats high-level disinfection of reusable devices among patients undergoing endoscopic retrograde cholangiopancreatography.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 22, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Rectal Diclofenac Likely Comparable to Rectal Indomethacin for Post-ERCP Pancreatitis Rectal Diclofenac Likely Comparable to Rectal Indomethacin for Post-ERCP Pancreatitis
An exploratory network analysis of post-retrograde cholangiopancreatography (ERCP) prophylaxis suggests that rectal diclofenac can be used interchangeably with rectal indomethacin to reduce costs, researchers say.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - July 19, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

AGA Shark Tank 2021: A Simple Design Survives AGA Shark Tank 2021: A Simple Design Survives
The winner is a device that overcomes a longstanding challenge presented by endoscopic retrograde cholangiopancreatography: biliary access.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 13, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Pandemic-Related Delays in Removing Intraductal Bile Duct Stents Can Be Harmful Pandemic-Related Delays in Removing Intraductal Bile Duct Stents Can Be Harmful
Priority should be given to timely removal of stents following recovery in patients who undergo endoscopic retrograde cholangiopancreatography with biliary stent placement, according to UK researchers.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 12, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Cirrhosis, Child-Pugh Score Predict ERCP Complications Cirrhosis, Child-Pugh Score Predict ERCP Complications
The risk for complications related to endoscopic retrograde cholangiopancreatography (ERCP) could be elevated in patients with cirrhosis, according to a retrospective study of almost 700 patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 4, 2020 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Boston Scientific Wins FDA Clearance for the World & #039;s First Fully Disposable Duodenoscope
Contamination on duodenoscopes after reprocessing continues to be a major concern in the United States, but a recent FDA clearance represents a major step toward combating the problem. Boston Scientific snagged clearance to sell its Exalt-D single-use duodenoscope in the United States to provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems. The Exalt-D is the first fully disposable duodenoscope to reach the market. The company is planning a limited U.S. market release of the device during the first quarter of 2...
Source: MDDI - December 13, 2019 Category: Medical Devices Tags: Business Regulatory and Compliance Source Type: news

CDx Diagnostics Founder and CSO Shares Company ’s Journey
CDx Diagnostics is on a mission to provide clinicians with tests and tools to preempt cancer through enhanced detection of precancerous cellular changes. The Suffern, NY-based company accomplishes this goal with WATS3, a diagnostic platform that synthesizes computer imaging, artificial intelligence, molecular biology and three-dimensional cytopathology to detect precancerous change earlier and more reliably than prior methods. MD+DI caught up with the company’s founder and CSO to discuss the evolution of the company and where it goes from here. MD+DI: Let’s talk a little bit about CDx D...
Source: MDDI - June 21, 2019 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

2 Devices That Could Clean Up the Dirty Scope Problem
Contamination on duodenoscopes after reprocessing continues to be a major concern in the United States. FDA recently reported that up to 5.4% of samples in postmarket studies tested positive for "high concern" organisms (those more often associated with disease, such as E. coli, and Pseudomonas aeruginosa), updated culturing results show that up to 5.4% of samples testing positive. On the bright side, at least two medical device manufacturers are actively trying to combat the issue. During Boston Scientific's first-quarter earnings call, CEO Mike Mahoney said the company is on track to l...
Source: MDDI - May 1, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: R & D Sterilization Source Type: news

GI Case Quiz: ERCP with Complications
After endoscopic retrograde cholangiopancreatography with stone extraction, the picture gets complicated for this 40-year-old woman. (Source: ConsultantLive)
Source: ConsultantLive - January 3, 2019 Category: Internal Medicine Authors: Ted W. James, MD Tags: Gastrointestinal Disorders Source Type: news

ERCP (Endoscopic Retrograde Cholangio-Pancreatography)
Title: ERCP (Endoscopic Retrograde Cholangio-Pancreatography)Category: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/18/2018 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 18, 2018 Category: Nutrition Source Type: news

ERCP During Lap Chole Tied to Best Outcomes for Choledocholithiasis ERCP During Lap Chole Tied to Best Outcomes for Choledocholithiasis
For patients with gallstones in the common bile duct, a so-called rendezvous approach is associated with the highest rates of safety and success compared with three other techniques, researchers in Italy say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - June 7, 2018 Category: Surgery Tags: Gastroenterology News Source Type: news

FDA Cracks Down on Duodenoscope Manufacturers Again
FDA doesn't like it when manufacturers ignore the agency's orders, as all three companies that make duodenoscope should probably have figured out by now. The company said it issued warning letters Friday to Olmpus, Pentax, and Fujifilm for failing to comply with post-market surveillance requirements to assess the effectiveness of reprocessing the devices. As part of an ongoing effort to prevent patient infections associated with the transmission of bacteria from contaminated duodenoscopes, FDA in 2015 ordered these manufacturers to conduct a post-market surveillance study to determine whether healthcare facilities were abl...
Source: MDDI - March 10, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Gore launches anti-migration assurance program for Viabil stent
W.L. Gore & Associates said today it launched an Anti-Migration Assurance Program for its Viabil short wire biliary endoprosthesis through which it will provide replacement devices for patients whose device moves out of place within a year of implantation. The Flagstaff, Ariz.-based company said the short wire biliary endoprosthesis has an average migration rate of 0.2%, touting the device as being the only “fully covered metal stent with demonstrated low migration and high long-term patency.” “Reintervention with additional stents and additional procedures increases the patient’s risk of complicat...
Source: Mass Device - October 4, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Stents W.L. Gore & Associates Source Type: news